Reduction of the major xenoantigen on glycosphingolipids of swine endothelial cells by various glycosyltransferases.
The effect of the various glycosyltransferases on glycosphingolipids was examined, using transfected swine endothelial cell (SEC) lines. The reactivity of parental SEC to normal human serum (NHS) and Griffonia simplicifolia IB(4) (GSIB4) lectin, which binds to the Gal alpha1-3 Gal beta 1-4 GlcNAc-R (alpha-galactosyl epitope), was reduced by approximately 20% by the treatment with D-PDMP (D-threo-1-phenyl-2-decan- oylamino-3-morpholino-1-propanol), suggesting that glycosphingolipids contained by SEC have a considerable amount of the alpha-galactosyl epitope. The overexpression of two different types of glycosyltransferase, N-acetylglucosaminyl transferase III (GnT-III), as well as alpha2, 6-sialyltransferase (ST6Gal I), alpha2,3-sialyltransferase (ST3Gal III), and alpha1,2-fucosyltransferase (alpha1,2FT), suppresses the total antigenicity of SEC significantly. However, the reduction in reactivities toward NHS and GSIB4 lectin in the case of GnT-III transfectants was milder than those in other transfectants. Western blot analysis indicated that the glycoproteins in all transfectants had diminished reactivity to NHS and GSIB4 lectin to approximately the same extent. Therefore, the neutral glycosphingolipids of these transfectants were separated by thin layer chromatography, followed by immunostaining with NHS and GSIB4 lectin. The levels of the alpha-galactosyl epitope in glycosphingolipids were not decreased in the GnT-III transfectants but were in the ST6Gal I, ST3Gal III, and alpha1,2FT transfectants. These data indicate that ST6Gal I, ST3Gal III, and alpha1,2FT reduced the alpha-galactosyl epitope in both glycoproteins and glycosphingolipids, while GnT-III reduced them only in glycoproteins.
Department of Biochemistry, Division of Organ Transplantation, Biomedical Research Center, Osaka University Graduate School of Medicine, Suita, Japan.
M
M
Koma
S
S
Miyagawa
K
K
Honke
Y
Y
Ikeda
S
S
Koyota
S
S
Miyoshi
H
H
Matsuda
S
S
Tsuji
R
R
Shirakura
N
N
Taniguchi
D000818:Animals; D015478:Antigens, Heterophile / Q000276:immunology* / Q000378:metabolism; D002460:Cell Line; D004727:Endothelium / Q000166:cytology / Q000276:immunology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D000939:Epitopes; D005697:Galactosides; D006028:Glycosphingolipids / Q000276:immunology* / Q000378:metabolism; D016695:Glycosyltransferases / Q000235:genetics / Q000378:metabolism*; D009025:Morpholines / Q000494:pharmacology; D013552:Swine / Q000276:immunology*; D014162:Transfection
D015478:Antigens, Heterophile; D004791:Enzyme Inhibitors; D000939:Epitopes; D005697:Galactosides; D006028:Glycosphingolipids; D009025:Morpholines; C033110:RV 538; D016695:Glycosyltransferases